Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kangbingdu oral liquid
- Development stage
- Unknown
- Lead developer
- Xiangxue Pharmaceutical
- Administration
- Oral
01
Overview
Kangbingdu oral liquid is a traditional Chinese medicine (TCM) formulation developed and marketed by Shandong Wohua Pharmaceutical. It is an oral solution indicated for the treatment of viral respiratory infections, specifically targeting symptoms such as dry and sore throat. As a complex herbal preparation, it contains multiple active botanical ingredients rather than a single chemical entity. It is widely used in China for its perceived antiviral and anti-inflammatory properties in the context of upper respiratory tract infections and the common cold.
- Brand names
- Kangbingdu
- Other names
- Antiviral oral liquidKangbingdu Koufuye抗病毒口服液
Beyond the preview
Go deeper on Kangbingdu oral liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kangbingdu oral liquid.